Antifibrotic	JJ
effects	NNS
of	IN
cyclosporine-A	NN
on	IN
TGF-b1-treated	JJ
lung	NN
fibroblasts	NNS
and	CC
lungs	NNS
from	IN
bleomycin-treated	JJ
mice	NNS
:	:
role	NN
of	IN
hypoxia-inducible-factor-1a	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
lung	NN
disorder	NN
that	WDT
is	VBZ
characterized	VBN
by	IN
aberrant	JJ
tissue	NN
remodeling	NN
and	CC
the	DT
formation	NN
of	IN
fibroblastic	JJ
foci	NNS
that	WDT
are	VBP
composed	VBN
of	IN
fibrogenic	JJ
myofibroblasts	NNS
.	.

TGF-b1	NN
is	VBZ
one	CD
of	IN
the	DT
factors	NNS
that	WDT
are	VBP
responsible	JJ
for	IN
fibrosis	NN
as	IN
it	PRP
promotes	VBZ
fibroblast	NN
to	TO
myofibroblast	NN
differentiation	NN
(	(
FMD	NN
)	)
and	CC
is	VBZ
associated	VBN
with	IN
up-regulation	NN
of	IN
a-smooth-muscle-actin	NN
.	.

Therefore	RB
,	,
inhibition	NN
of	IN
FMD	NN
may	MD
represent	VB
an	DT
effective	JJ
strategy	NN
for	IN
the	DT
treatment	NN
of	IN
IPF	NN
.	.

Here	RB
,	,
we	PRP
describe	VBP
the	DT
treatment	NN
of	IN
human	JJ
lung	NN
fibroblasts	NNS
(	(
WI-38	NN
and	CC
HFL-1	NN
cells	NNS
)	)
with	IN
cyclosporine-A	NN
(	(
CsA	NN
)	)
,	,
which	WDT
reduces	VBZ
TGF-b1-induced	JJ
FMD	NN
via	IN
degradation	NN
of	IN
hypoxia-inducible-factor-1a	NN
(	(
HIF-1a	NN
)	)
.	.

In	IN
addition	NN
,	,
in	IN
primary	JJ
myofibroblast-like	JJ
cells	NNS
that	WDT
were	VBD
obtained	VBN
from	IN
a	DT
patient	NN
with	IN
pulmonary	JJ
fibrosis	NN
,	,
treatment	NN
with	IN
CsA	NN
and	CC
an	DT
HIF-1a	NN
inhibitor	NN
(	(
HIFi	NN
)	)
decreased	VBD
the	DT
expression	NN
levels	NNS
of	IN
a-smooth-muscle-actin	NN
and	CC
fibronectin	NN
,	,
which	WDT
indicated	VBD
that	IN
CsA	NN
and	CC
HIFi	NN
promote	VBP
dedifferentiation	NN
of	IN
myofibroblasts	NNS
.	.

In	IN
mice	NNS
intratracheally	RB
administered	VBN
CsA	NN
or	CC
HIFi	NNS
at	IN
an	DT
early	JJ
fibrotic	JJ
stage	NN
[	(
7	CD
,	,
8	CD
,	,
and	CC
9	CD
d	NN
postinstillation	NN
(	(
dpi	NN
)	)
of	IN
bleomycin	NN
]	)
,	,
marked	JJ
alleviation	NN
of	IN
lung	NN
fibrosis	NN
was	VBD
observed	VBN
at	IN
14	CD
dpi	NN
.	.

These	DT
results	NNS
suggest	VBP
that	IN
CsA	NN
exhibits	VBZ
antifibrotic	JJ
effects	NNS
by	IN
degrading	VBG
HIF-1a	NN
and	CC
that	IN
the	DT
CsA-HIF-1a	NN
axis	NN
provides	VBZ
new	JJ
insights	NNS
into	IN
therapeutic	JJ
options	NNS
for	IN
the	DT
treatment	NN
of	IN
IPF.-Yamazaki	NN
,	,
R.	NNP
,	,
Kasuya	NNP
,	,
Y.	NNP
,	,
Fujita	NNP
,	,
T.	NNP
,	,
Umezawa	NNP
,	,
H.	NNP
,	,
Yanagihara	NNP
,	,
M.	NNP
,	,
Nakamura	NNP
,	,
H.	NNP
,	,
Yoshino	NNP
,	,
I.	NNP
,	,
Tatsumi	NNP
,	,
K.	NNP
,	,
Murayama	NNP
,	,
T.	NNP
Antifibrotic	NNP
effects	NNS
of	IN
cyclosporine-A	NN
on	IN
TGF-b1-treated	JJ
lung	NN
fibroblasts	NNS
and	CC
lungs	NNS
from	IN
bleomycin-treated	JJ
mice	NNS
:	:
role	NN
of	IN
hypoxia-inducible-factor-1a	NN
.	.

